2026年1月6日，和铂医药控股有限公司（02142）披露截至2025年12月31日的股份变动月报。报告显示，该公司法定注册资本维持20,000,000,000股，面值每股USD0.000025，总额USD500,000，月内未发生任何变动。
截至2025年11月30日，公司已发行股份（不含库存股份）为869,456,522股，库存股份为24,337,000股，合计893,793,522股。12月内，已发行股份净减少775,000股，库存股份增加1,100,000股，期末数据分别为868,681,522股与25,437,000股，共计894,118,522股。
期内，公司继续执行首次公开发售后购股权计划，因行使期权增发325,000股。另根据多次购回安排，共计1,100,000股转为库存股份，另有406,000股处于拟注销但截至月末尚未注销状态。
公司声明已遵守香港联合交易所有限公司《上市规则》及所有相关法律规定。本次月报由执行董事王劲松签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.